Adrenal metastasis from a primary papillary thyroid carcinoma

Internal Medicine

Volumn 47, Issue 24, 2008, Pages 2165-2168

  Wagenaar, Nils ^a   Oosterhuis, Jan Wolter Adriaan ^a   Rozendaal, Lawrence ^a   Comans, Emile ^a   Simsek, Suat ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Adrenal metastasis; Papillary thyroid carcinoma; PET CT; Total body iodine scan

Indexed keywords

FLUORODEOXYGLUCOSE F 18; IODINE 131; THYROGLOBULIN; THYROID TRANSCRIPTION FACTOR 1; THYROTROPIN;

ADRENAL GLAND; ADRENAL METASTASIS; AGED; ARTICLE; CANCER INVASION; CANCER SURGERY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DRUG UPTAKE; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LOW DRUG DOSE; NECK DISSECTION; NECK TUMOR; OUTPATIENT CARE; POSITRON EMISSION TOMOGRAPHY; RETROSTERNAL GOITER; SUBTOTAL THYROIDECTOMY; THYROID PAPILLARY CARCINOMA; TRACHEA; WHOLE BODY SCINTISCANNING;

ADRENAL GLAND NEOPLASMS; AGED; CARCINOMA, PAPILLARY; FEMALE; HUMANS; THYROID NEOPLASMS;

EID: 61749095926     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.47.1582     Document Type: Article

References (12)

1. Davies L, Welch HG. Increasing incidence of thyroid cancer in the United States, 1973-2002 JAMA 295: 2164-2167, 2005.
2. Mitchell I, Livingston E, Chang A, et al. Trends in thyroid cancer demographics and surgical therapy in the United States. Surgery 142: 823-828, 2007.
3. Bilimoria KY, Bentrem DJ, Ko CY, et al. Extent of surgery affects survival for papillary thyroid cancer. Ann Surg 246: 375-384, 2007.
4. Fatourechi V, Hay ID, Mullan BP, et al. Are posttherapy radioiodine scans informative and do they influence subsequent therapy of patients with differentiated thyroid cancer. Thyroid 10: 573-577, 2000.
5. Copland JA, Marlow LA, Williams SF, et al. Molecular diagnosis of a BRAF papillary thyroid carcinoma with multiple chromosome abnormalities and rare adrenal and hypothalamic metastases. Thyroid 16: 1293-1302, 2006.
6. Koutkia P, Safer JD. Adrenal metastasis secondary to papillary thyroid carcinoma. Thyroid 11: 1077-1079, 2001.
7. Aissaoui R, Turki Z, Achiche A, Balti MH, Ben Slama C, Zbiba M. Adrenal metastasis of a papillary thyroid cancer. Ann Endocrinol 67: 364-367, 2006.
8. Bilimoria KY, Bentrem DJ, Linn JG, et al. Utilization of total thyroidectomy for papillary thyroid cancer in the United States. Surgery 142: 906-913, 2007.
9. 131I scanning results after therapy. Journal of Nuclear Medicine 42: 1464-1469, 2001.
10. Nahas Z, Goldenberg D, Fakhry C, et al. The role of positron emission tomography/computed tomography in the management of recurrent papillary thyroid carcinoma. Laryngoscope 115: 237-243, 2005.
11. 131I whole body scans and elevated serum thyroglobulin levels. J Clin Endocrinol Metab 84: 2291-2302, 1999.
12. Feine U, Lietzenmayer R, Hanke JP, Held J, Wohrle H, Müller-Schauenburg W. Fluorine-18-FDG and iodine-131-iodide uptake in thyroid cancer. Journal of Nuclear Medicine 37: 1468-1472, 1996.